{"id":211290,"date":"2026-08-19T10:54:43","date_gmt":"2026-08-19T05:24:43","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=211290"},"modified":"2026-08-19T10:54:43","modified_gmt":"2026-08-19T05:24:43","slug":"why-bliss-gvs-pharma-ltd-share-price-52-week-high-2026-08-19","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-ltd-share-price-52-week-high-2026-08-19\/","title":{"rendered":"Bliss GVS Pharma Ltd. (BLISSGVS-BE) Share Price Hits Fresh 52-Week High"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><a href=\"https:\/\/univest.in\/stocks\/blissgvs\/bliss-gvs-pharma-ltd-share-price-today\">Bliss GVS Pharma Ltd.<\/a> Share Price rose 5% to Rs 572.70, its fresh 52-week high, taking market capitalisation to Rs 5,521 crore.<\/p>\n<p style=\"margin-top:0!important;\">Bliss GVS Pharma Ltd. Share Price moved up to Rs 572.70 on 19 August 2026, a gain of Rs 27.25 or 5% from the previous close of Rs 545.45, while marking a fresh 52-week high. The stock opened at Rs 569.75, traded between Rs 551.05 and Rs 572.70 during the session, and the company\u2019s market capitalisation stood at Rs 5,521 crore.<\/p>\n<p>For readers tracking Bliss GVS Pharma Ltd. Share Price Today and Bliss GVS Pharma Ltd. Stock News, the verified data confirms a clear price event: the stock touched a new one-year high and was trading at the top of its day\u2019s range. Turnover stood at Rs 1.51 crore with current volume of 26,390 shares, showing active participation around the yearly high.<\/p>\n<p>What the supplied data establishes is the price breakout itself, not a company-specific catalyst. That still makes this a relevant stock analysis event because fresh 52 Week High stocks often attract attention across Stock Market Today screens, Market Movers lists and momentum-focused watchlists. In Univest\u2019s view, the next things to monitor are whether Bliss GVS Pharma Ltd. Share Price can hold near this 52-week peak, how its valuation compares with the Healthcare benchmark, and whether its profitability metrics support continued investor interest.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Bliss_GVS_Pharma_Ltd_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Bliss GVS Pharma Ltd. Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 572.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 545.45<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Change<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 27.25 (+5%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 569.75<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Fresh 52-Week High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 572.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 551.05<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26,390<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1.51 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5,521 crore<\/td>\n<\/tr>\n<\/table>\n<p>Bliss GVS Pharma Ltd. (BLISSGVS-BE) traded at Rs 572.7. versus the previous close of Rs 545.45, a rise of 5%. The stock opened at Rs 569.75, reached Rs 572.7, touched Rs 551.05. Reported volume was 26,390.<\/p>\n<p>Bliss GVS Pharma Ltd. Share Price Today reflects a strong session on verified price data alone. The stock rose 5% from the previous close of Rs 545.45 to Rs 572.70, opened at Rs 569.75, touched a low of Rs 551.05 and hit a fresh 52-week high of Rs 572.70.<\/p>\n<p>The day\u2019s move is notable because the stock finished its intraday climb at the same level as its 52-week high, indicating that the session\u2019s strongest quoted price was also the new one-year high. A rise of Rs 27.25 from the previous close is meaningful on an event-driven basis, especially when the stock is appearing in 52 Week High Stocks and Stocks in News screens.<\/p>\n<p>Intraday positioning also matters. Opening at Rs 569.75 and then reaching Rs 572.70 shows the stock stayed close to the upper end of its session range for much of the move, even after dipping to Rs 551.05. That places Bliss GVS Pharma Ltd. Share Price near the top of the day\u2019s price action rather than merely tagging the level briefly.<\/p>\n<p>Trading turnover of Rs 1.51 crore and volume of 26,390 shares indicate measurable market participation behind the move. The supplied data confirms the breakout event, but it does not establish a company-specific reason for why the stock is rising today. For investors following Bliss GVS Pharma Ltd. Share News and Bliss GVS Pharma Ltd. Share Price Live, the next step is to judge whether the current move is supported by the company\u2019s valuation and return profile.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Bliss_GVS_Pharma_Ltd_BLISSGVS-BE_Fundamental_Analysis\"><\/span><strong>Bliss GVS Pharma Ltd. (BLISSGVS-BE) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5,521 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">51.17x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.03x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-0.78%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">8.31%<\/td>\n<\/tr>\n<\/table>\n<p>Bliss GVS Pharma Ltd. was valued at a P\/E ratio of 51.17x, a P\/B ratio of 2.03x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.<\/p>\n<p>Profitability and capital efficiency were represented by ROE of -0.78% and ROCE of 8.31%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same sector<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">51.17x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.79x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">47.16x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 1,635.98x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.03x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.9x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-0.78%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.09%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">8.31%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.29%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5,521 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 134.22 crore<\/td>\n<\/tr>\n<\/table>\n<p>Bliss GVS Pharma Ltd. (BLISSGVS-BE) is classified under sector: Healthcare.<\/p>\n<p>Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a P\/E ratio of 51.17x, which is above the benchmark median of 20.79x, a difference of +146.13%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a ROE of -0.78%, which is below the benchmark median of 11.09%, a difference of -107.03%. Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a ROCE of 8.31%, which is below the benchmark median of 13.29%, a difference of -37.47%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/indswftlab\/ind-swift-laboratories-ltd-share-price-today\"><strong>Ind-Swift Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">INDSWFTLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,724.51<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">51.17<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.03<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.78<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.31<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\"><strong>Beta Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BETA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,697.08<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">62.93<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.96<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.17<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dragarwq\/dr-agarwals-eye-hospital-ltd-share-price-today\"><strong>Dr Agarwals Eye Hospital Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DRAGARWQ<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,583.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.9<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.99<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">36.29<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">42.4<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/saiparent\/sai-parenteral-s-ltd-share-price-today\"><strong>Sai Parenteral&#39;s Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SAIPARENT<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,431.62<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">167.79<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.07<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.9<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.97<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/fredun\/fredun-pharmaceuticals-ltd-share-price-today\"><strong>Fredun Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">FREDUN<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,403.56<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">54.45<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.13<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.42<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.15<\/td>\n<\/tr>\n<\/table>\n<p>Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a P\/E ratio of 51.17x compared with the displayed peer median of 54.45x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -0.78% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at 8.31% versus the displayed peer median of 13.15%, providing a capital-efficiency comparison. Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a market capitalisation of Rs 5,521 crore. Among the 5 peers shown, 0 have a larger market capitalisation.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Bliss_GVS_Pharma_Ltd\"><\/span><strong>Why Investors Are Watching Bliss GVS Pharma Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The current attention around Bliss GVS Pharma Ltd. Share Price is grounded in verified market data and relative valuation context rather than any stated corporate trigger.<\/p>\n<ul>\n<li><strong>Fresh price event:<\/strong> the stock hit a new 52-week high of Rs 572.70 and rose 5% in the session.<\/li>\n<li><strong>Strong intraday placement:<\/strong> the day\u2019s high matched the current price, showing the stock was trading at the top of the session range.<\/li>\n<li><strong>Meaningful activity:<\/strong> turnover reached Rs 1.51 crore with volume of 26,390 shares.<\/li>\n<li><strong>Large market size:<\/strong> market capitalisation of Rs 5,521 crore is above the supplied Healthcare benchmark average and median.<\/li>\n<li><strong>Valuation debate:<\/strong> P\/E of 51.17 is above the sector median of 20.79 and above the average of 47.16.<\/li>\n<li><strong>Return profile:<\/strong> ROE of -0.78% and ROCE of 8.31% trail the sector medians of 11.09% and 13.29%.<\/li>\n<li><strong>Peer relevance:<\/strong> the stock is larger than the supplied peers by market cap, but not stronger on the supplied return ratios.<\/li>\n<\/ul>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_Bliss_GVS_Pharma_Ltd\"><\/span><strong>About Bliss GVS Pharma Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Bliss GVS Pharma Ltd. is being tracked here as a listed Healthcare company under the symbol BLISSGVS-BE. The supplied dataset places it within the Healthcare sector, which is the reference universe used for the valuation and profitability benchmark in this article.<\/p>\n<p>Because this report is built only from verified event data, the focus remains on what can be confirmed in the supplied record: the company\u2019s market value, its fresh 52-week high, and how Bliss GVS Pharma Ltd. Share Price compares with sector and peer metrics. In the current Market News cycle, that is enough to place the stock on investor watchlists even without adding unsupported business detail.<\/p>\n<p>For readers using Univest for Bliss GVS Pharma Ltd. Stock News, the stock is currently notable for its one-year high, its Rs 5,521 crore market capitalisation, and a valuation profile that sits above broad Healthcare earnings benchmarks while showing lower supplied return ratios than many peers.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_Bliss_GVS_Pharma_Ltd_Share_Price_on_Univest\"><\/span><strong>Track Bliss GVS Pharma Ltd. Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/blissgvs\/bliss-gvs-pharma-ltd-share-price-today\">Bliss GVS Pharma Ltd. (BLISSGVS-BE) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>On Univest, users can track Bliss GVS Pharma Ltd. Share Price through live market updates, 52-week levels, price performance, turnover trends and broader stock analysis. The platform also helps investors follow key fundamental ratios such as market cap, P\/E, P\/B, ROE and ROCE in one place.<\/p>\n<p>For readers monitoring Bliss GVS Pharma Ltd. Share Price Today, Univest also brings together peer comparison, sector benchmark context and day-by-day market insights. That makes it easier to place a fresh 52-week high in context rather than viewing the price move in isolation. As this event shows, a one-year high can draw attention quickly, but the more useful question is how the price action compares with valuation and sector positioning.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_latest_Bliss_GVS_Pharma_Ltd_Share_Price_Today\"><\/span><strong>What is the latest Bliss GVS Pharma Ltd. Share Price Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Bliss GVS Pharma Ltd. Share Price Today is Rs 572.70. The stock was up Rs 27.25, or 5%, from the previous close of Rs 545.45, and this move also marked a fresh 52-week high during the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Bliss_GVS_Pharma_Ltd_Share_Price_in_focus_today\"><\/span><strong>Why is Bliss GVS Pharma Ltd. Share Price in focus today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock is in focus because it hit a fresh 52-week high of Rs 572.70 on 19 August 2026. The supplied data confirms the price breakout and a 5% daily gain, though it does not establish a company-specific catalyst.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_intraday_range_for_Bliss_GVS_Pharma_Ltd_Share_Price\"><\/span><strong>What was the intraday range for Bliss GVS Pharma Ltd. Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Bliss GVS Pharma Ltd. Share Price opened at Rs 569.75, touched an intraday low of Rs 551.05 and reached a high of Rs 572.70. That means the stock ended up trading at the same level as its fresh yearly high.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Bliss_GVS_Pharma_Ltd\"><\/span><strong>What is the market capitalisation of Bliss GVS Pharma Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Bliss GVS Pharma Ltd. had a market capitalisation of Rs 5,521 crore in the supplied dataset. That is well above the Healthcare sector benchmark median of Rs 134.22 crore and also above the benchmark average of Rs 465.93 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Bliss_GVS_Pharma_Ltd_compare_on_PE_ratio\"><\/span><strong>How does Bliss GVS Pharma Ltd. compare on P\/E ratio?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The company\u2019s P\/E ratio is 51.17. This is above the Healthcare benchmark median of 20.79 and also above the benchmark average of 47.16, indicating that the stock trades at a richer earnings multiple than broad sector norms.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_the_PB_ratio_of_Bliss_GVS_Pharma_Ltd_show\"><\/span><strong>What does the P\/B ratio of Bliss GVS Pharma Ltd. show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Bliss GVS Pharma Ltd. has a P\/B ratio of 2.03. That is slightly above the Healthcare sector median of 1.9 but below the sector average of 2.57, placing its balance-sheet valuation closer to the middle of the benchmark range.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_strong_are_the_return_ratios_of_Bliss_GVS_Pharma_Ltd\"><\/span><strong>How strong are the return ratios of Bliss GVS Pharma Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied data shows ROE at -0.78% and ROCE at 8.31%. Both are below the Healthcare benchmark medians of 11.09% and 13.29%, so the current one-year high is not accompanied by top-tier return ratios.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_active_was_trading_in_Bliss_GVS_Pharma_Ltd_shares_today\"><\/span><strong>How active was trading in Bliss GVS Pharma Ltd. shares today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Trading volume stood at 26,390 shares, while turnover was Rs 1.51 crore. Those figures indicate active participation on the day the stock rose 5% and touched its fresh 52-week peak at Rs 572.70.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Bliss_GVS_Pharma_Ltd_compare_with_the_supplied_peers\"><\/span><strong>How does Bliss GVS Pharma Ltd. compare with the supplied peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Bliss GVS Pharma Ltd. has a market cap of Rs 5,521 crore, larger than all supplied peers. However, its ROE of -0.78% and ROCE of 8.31% are weaker than Beta Drugs, Dr Agarwals Eye Hospital, Sai Parenteral&#39;s and Fredun Pharmaceuticals.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_after_this_52-week_high\"><\/span><strong>What should investors monitor after this 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors can monitor whether Bliss GVS Pharma Ltd. Share Price holds near Rs 572.70, how valuation at 51.17 times earnings evolves, and whether future data improves return ratios that currently stand at ROE of -0.78% and ROCE of 8.31%.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bliss GVS Pharma Ltd. Share Price hits a new 52-week high at Rs 572.7. marking a 5% rise today. Market cap stands at Rs 5,521 crore.<\/p>\n","protected":false},"author":29,"featured_media":211288,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-211290","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["211288"],"rank_math_title":["Bliss GVS Pharma Ltd. Share Price at Fresh 52-Week High"],"rank_math_description":["Bliss GVS Pharma Ltd. Share Price hit a fresh 52-week high at Rs 572.70. Check price action, valuation, peer comparison and sector analysis."],"rank_math_focus_keyword":["Bliss GVS Pharma Ltd. Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/Bliss_GVS_Pharma_Ltd_BLISSGVS_BE_Share_Price_Hits_Fresh_52_Week_High_bullish-1.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/211290","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=211290"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/211290\/revisions"}],"predecessor-version":[{"id":211291,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/211290\/revisions\/211291"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/211288"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=211290"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=211290"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=211290"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}